Novavax to Host Conference Call to Discuss Second Quarter 2023 Financial Results and Operational Highlights on August 8, 2023

Rhea-AI Summary

Novavax, Inc. will report its second quarter 2023 financial results and operational highlights on August 8, 2023, at 8:30 a.m. EDT. The conference call details and replay information are provided in the press release.

GAITHERSBURG, Md., Aug. 1, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced it will report its second quarter 2023 financial results and operational highlights at 8:30 a.m. Eastern Daylight Time (EDT) on Tuesday, August 8, 2023. Details of the event and replay are as follows:

Conference call details:
Date:	August 8, 2023
Time:	8:30 a.m. U.S. EDT
Dial-in number:	(877) 883-0383 (Domestic) or (412) 902-6506 (International)
Passcode:	1209328
Webcast:	ir.novavax.com/events

• Participants will be prompted to request to join the Novavax, Inc. call.
• To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.

Replay details:
Date:	Available starting at 11:30 a.m. EDT, August 8, 2023, until 11:59 p.m. U.S. EDT, August 15, 2023
Dial-in number:	(877) 344-7529 (Domestic) or (412) 317-0088 (International)
Passcode:	2287018
Webcast:	ir.novavax.com/events, until November 6, 2023

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID, influenza, and COVID and influenza combined. Please visit novavax.com and LinkedIn for more information.

Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com

Media
Ali Chartan
240-720-7804
media@novavax.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-second-quarter-2023-financial-results-and-operational-highlights-on-august-8-2023-301890257.html

SOURCE Novavax, Inc.

FAQ

When will Novavax, Inc. report its second quarter 2023 financial results?

Novavax, Inc. will report its second quarter 2023 financial results on August 8, 2023.

What time will the financial results be announced?

The financial results will be announced at 8:30 a.m. Eastern Daylight Time (EDT).

Where can I access the conference call?

You can access the conference call at ir.novavax.com/events.

What is the dial-in number for the conference call?

The dial-in number for the conference call is (877) 883-0383 (Domestic) or (412) 902-6506 (International).

What is the passcode for the conference call?

The passcode for the conference call is 1209328.

When will the replay of the conference call be available?

The replay of the conference call will be available starting at 11:30 a.m. EDT on August 8, 2023, until 11:59 p.m. EDT on August 15, 2023.

What is the dial-in number for the replay of the conference call?

The dial-in number for the replay of the conference call is (877) 344-7529 (Domestic) or (412) 317-0088 (International).

What is the passcode for the replay of the conference call?

The passcode for the replay of the conference call is 2287018.

Until when will the webcast of the conference call be available?

The webcast of the conference call will be available until November 6, 2023, at ir.novavax.com/events.